A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus

• Главные авторы: Bang Sun-Hwi (Автор), Yoon Jeung-Won (Автор), Cho Chong-Kwan (Автор), Shin Ji-Eun (Автор), Lee Yeon-Weol (Автор), Yoo Hwa-Seung (Автор)
• Формат: ‌
• Опубликовано: Korean Pharmacopuncture Institute, 2012-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background and Objectives: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus (HAP) has been developed...